Results 181 to 190 of about 68,801 (240)
JAMA Netw OpenSome of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Internal Medicine, 2002
The ability to use an effective treatment constitutes a main concern in the management of acute ischemic stroke. Randomized trials have so far failed to demonstrate any beneficial effect of neuroprotective agents on neurologic outcome after an acute stroke. Thrombolytic agents can achieve early recanalization of an occluded intracerebral artery.
Katayoun, Vahedi +1 more
openaire +2 more sources
The ability to use an effective treatment constitutes a main concern in the management of acute ischemic stroke. Randomized trials have so far failed to demonstrate any beneficial effect of neuroprotective agents on neurologic outcome after an acute stroke. Thrombolytic agents can achieve early recanalization of an occluded intracerebral artery.
Katayoun, Vahedi +1 more
openaire +2 more sources
European Journal of Neurology, 2012
Background and purposeHemiplegia at stroke onset may be considered a contraindication for thrombolytic therapy. We describe the outcome of patients with ischaemic stroke presenting with hemiplegia and treated with intravenous alteplase (tPA).MethodsAll patients treated with tPA for acute ischaemic stroke between 1995 and 2010 were prospectively ...
Meretoja A. +11 more
openaire +2 more sources
Background and purposeHemiplegia at stroke onset may be considered a contraindication for thrombolytic therapy. We describe the outcome of patients with ischaemic stroke presenting with hemiplegia and treated with intravenous alteplase (tPA).MethodsAll patients treated with tPA for acute ischaemic stroke between 1995 and 2010 were prospectively ...
Meretoja A. +11 more
openaire +2 more sources
Archives of Neurology, 1996
On June6,1996, the Peripheral and Central Nervous System Drug Advisory Committee to the US Food and Drug Administration (FDA) voted 10 to 0 that tissue-type plasminogen activator (t-PA [lateplase]) is safe and effective therapy for acute ischemic stroke.
openaire +2 more sources
On June6,1996, the Peripheral and Central Nervous System Drug Advisory Committee to the US Food and Drug Administration (FDA) voted 10 to 0 that tissue-type plasminogen activator (t-PA [lateplase]) is safe and effective therapy for acute ischemic stroke.
openaire +2 more sources
British Journal of Haematology, 2009
SummaryThrombosis in children may result in vascular occlusion and a potential loss of viability in skin, limbs or organs, or lead to the development of post thrombotic syndrome. Thrombolysis may prevent such complications, and the use of thrombolytics in children has increased in the last three decades.
openaire +2 more sources
SummaryThrombosis in children may result in vascular occlusion and a potential loss of viability in skin, limbs or organs, or lead to the development of post thrombotic syndrome. Thrombolysis may prevent such complications, and the use of thrombolytics in children has increased in the last three decades.
openaire +2 more sources
Thrombosis and Haemostasis, 1999
SummaryThe possibility of lysing clots by the direct intravascular application of ultrasound was described first in 1974 in an animal experiment. However research on therapeutic ultrasound for thrombolysis gained momentum in the early 1980s and is now divided into several directions: 1) pharmacological thrombolysis supported by externally applied ...
openaire +2 more sources
SummaryThe possibility of lysing clots by the direct intravascular application of ultrasound was described first in 1974 in an animal experiment. However research on therapeutic ultrasound for thrombolysis gained momentum in the early 1980s and is now divided into several directions: 1) pharmacological thrombolysis supported by externally applied ...
openaire +2 more sources